Fridland A - Search Results

1

Lack of a metabolic and antiviral drug interaction between tenofovir, abacavir and lamivudine.

Ray AS, Myrick F, Vela JE, Olson LY, Eisenberg EJ, Borroto-Esodo K, Miller MD, Fridland A. Ray AS, et al. Among authors: fridland a. Antivir Ther. 2005;10(3):451-7. Antivir Ther. 2005. PMID: 15918336

2

Role of purine nucleoside phosphorylase in interactions between 2',3'-dideoxyinosine and allopurinol, ganciclovir, or tenofovir.

Ray AS, Olson L, Fridland A. Ray AS, et al. Among authors: fridland a. Antimicrob Agents Chemother. 2004 Apr;48(4):1089-95. doi: 10.1128/AAC.48.4.1089-1095.2004. Antimicrob Agents Chemother. 2004. PMID: 15047506 Free PMC article.

3

Effective metabolism and long intracellular half life of the anti-hepatitis B agent adefovir in hepatic cells.

Ray AS, Vela JE, Olson L, Fridland A. Ray AS, et al. Among authors: fridland a. Biochem Pharmacol. 2004 Nov 1;68(9):1825-31. doi: 10.1016/j.bcp.2004.07.010. Biochem Pharmacol. 2004. PMID: 15450948

4

Simultaneous quantitation of the nucleotide analog adefovir, its phosphorylated anabolites and 2'-deoxyadenosine triphosphate by ion-pairing LC/MS/MS.

Vela JE, Olson LY, Huang A, Fridland A, Ray AS. Vela JE, et al. Among authors: fridland a. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):335-43. doi: 10.1016/j.jchromb.2006.10.063. Epub 2006 Nov 13. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17101307

5

GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma.

Reiser H, Wang J, Chong L, Watkins WJ, Ray AS, Shibata R, Birkus G, Cihlar T, Wu S, Li B, Liu X, Henne IN, Wolfgang GH, Desai M, Rhodes GR, Fridland A, Lee WA, Plunkett W, Vail D, Thamm DH, Jeraj R, Tumas DB. Reiser H, et al. Among authors: fridland a. Clin Cancer Res. 2008 May 1;14(9):2824-32. doi: 10.1158/1078-0432.CCR-07-2061. Clin Cancer Res. 2008. PMID: 18451250

6

Cellular factors for resistance against antiretroviral agents.

Fridland A, Connelly MC, Robbins BL. Fridland A, et al. Antivir Ther. 2000 Sep;5(3):181-5. Antivir Ther. 2000. PMID: 11075937 Review.

7

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) inhibits HIV-1 replication in epithelial cells, but not T-lymphocytes.

Srinivas RV, Connely M, Fridland A. Srinivas RV, et al. Among authors: fridland a. Antiviral Res. 1997 Jun;35(1):23-7. doi: 10.1016/s0166-3542(97)01035-8. Antiviral Res. 1997. PMID: 9224958

8

Metabolism of tenofovir and didanosine in quiescent or stimulated human peripheral blood mononuclear cells.

Robbins BL, Wilcox CK, Fridland A, Rodman JH. Robbins BL, et al. Among authors: fridland a. Pharmacotherapy. 2003 Jun;23(6):695-701. doi: 10.1592/phco.23.6.695.32189. Pharmacotherapy. 2003. PMID: 12820810

9

MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs.

Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV, Kumar A, Fridland A. Schuetz JD, et al. Among authors: fridland a. Nat Med. 1999 Sep;5(9):1048-51. doi: 10.1038/12487. Nat Med. 1999. PMID: 10470083

10

Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients.

Robbins BL, Tran TT, Pinkerton FH Jr, Akeb F, Guedj R, Grassi J, Lancaster D, Fridland A. Robbins BL, et al. Among authors: fridland a. Antimicrob Agents Chemother. 1998 Oct;42(10):2656-60. doi: 10.1128/AAC.42.10.2656. Antimicrob Agents Chemother. 1998. PMID: 9756772 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page